Polymorphisms in the ADRB2 gene and Graves disease: a case-control study and a meta-analysis of available evidence

Xun Chu,Yan Dong,Min Shen,Lingling Sun,Changzheng Dong,Yi Wang,Beilan Wang,Kaiyue Zhang,Qi Hua,Shijie Xu,Wei Huang
DOI: https://doi.org/10.1186/1471-2350-10-26
2009-01-01
BMC Medical Genetics
Abstract:The beta-2-Adrenergic receptor (ADRB2) gene on chromosome 5q33.1 is an important immunoregulatory factor. We and others have previously implicated chromosomal region 5q31-33 for contribution to the genetic susceptibility to Graves disease (GD) in East-Asian populations. Two recent studies showed associations between the single nucleotide polymorphism (SNP) rs1042714 in the ADRB2 gene and GD. In this study, we aimed to fully investigate whether the ADRB2 gene conferred susceptibility to GD in Chinese population, and to perform a meta-analysis of association between ADRB2 and GD.
What problem does this paper attempt to address?